Variables | Olanexidine group (n = 116) | Chlorhexidine group (n = 114) | p value |
---|---|---|---|
Age (mean ± S.D.) | 67.9 ± 3.7 | 67.8 ± 4.4 | 0.51 |
Gender (M:F) | 103:13 | 101:13 | 0.96 |
Body Mass Index (mean ± S.D.) | 22.1 ± 2.2 | 21.9 ± 2.3 | 0.61 |
ASA Grade | 0.47 | ||
Grade 1 | 45 | 39 | |
Grade 2 | 71 | 75 | |
Pre-operative treatment | 0.13 | ||
Chemotherapy | 71 | 47 | |
Chemo-radiation | 8 | 11 | |
Clinical stage (UICC 7th) | 0.99 | ||
Stage I | 29 | 30 | |
Stage II | 20 | 22 | |
Stage III | 59 | 55 | |
Stage IV | 8 | 7 | |
Type of surgical approach | 0.47 | ||
Thoracoscopic | 98 | 100 | |
Thoracotomy | 18 | 14 | |
Type of surgical approach | 0.56 | ||
Laparoscopic | 101 | 103 | |
Laparotomy | 15 | 11 |